Literature DB >> 30635416

Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus.

Richard Copin1, William E Sause2, Yi Fulmer1, Divya Balasubramanian2, Sophie Dyzenhaus2, Jamil M Ahmed1, Krishan Kumar1, John Lees2, Anna Stachel1, Jason C Fisher3, Karl Drlica4,5, Michael Phillips1, Jeffrey N Weiser2, Paul J Planet6, Anne-Catrin Uhlemann7, Deena R Altman8,9, Robert Sebra9, Harm van Bakel9, Jennifer Lighter10, Victor J Torres11, Bo Shopsin12,2.   

Abstract

The past two decades have witnessed an alarming expansion of staphylococcal disease caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). The factors underlying the epidemic expansion of CA-MRSA lineages such as USA300, the predominant CA-MRSA clone in the United States, are largely unknown. Previously described virulence and antimicrobial resistance genes that promote the dissemination of CA-MRSA are carried by mobile genetic elements, including phages and plasmids. Here, we used high-resolution genomics and experimental infections to characterize the evolution of a USA300 variant plaguing a patient population at increased risk of infection to understand the mechanisms underlying the emergence of genetic elements that facilitate clonal spread of the pathogen. Genetic analyses provided conclusive evidence that fitness (manifest as emergence of a dominant clone) changed coincidently with the stepwise emergence of (i) a unique prophage and mutation of the regulator of the pyrimidine nucleotide biosynthetic operon that promoted abscess formation and colonization, respectively, thereby priming the clone for success; and (ii) a unique plasmid that conferred resistance to two topical microbiocides, mupirocin and chlorhexidine, frequently used for decolonization and infection prevention. The resistance plasmid evolved through successive incorporation of DNA elements from non-S. aureus spp. into an indigenous cryptic plasmid, suggesting a mechanism for interspecies genetic exchange that promotes antimicrobial resistance. Collectively, the data suggest that clonal spread in a vulnerable population resulted from extensive clinical intervention and intense selection pressure toward a pathogen lifestyle that involved the evolution of consequential mutations and mobile genetic elements.

Entities:  

Keywords:  MRSA; antimicrobial resistance; evolution; virulence

Mesh:

Substances:

Year:  2019        PMID: 30635416      PMCID: PMC6358666          DOI: 10.1073/pnas.1814265116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  108 in total

Review 1.  The suckling mouse model of cholera.

Authors:  K E Klose
Journal:  Trends Microbiol       Date:  2000-04       Impact factor: 17.079

2.  Characterization of the interaction of Bacillus subtilis PyrR with pyr mRNA by site-directed mutagenesis of the protein.

Authors:  Heather K Savacool; Robert L Switzer
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

Review 3.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Long-time persistence of superantigen-producing Staphylococcus aureus strains in the intestinal microflora of healthy infants.

Authors:  E Lindberg; F Nowrouzian; I Adlerberth; A E Wold
Journal:  Pediatr Res       Date:  2000-12       Impact factor: 3.756

5.  Allergy development and the intestinal microflora during the first year of life.

Authors:  B Björkstén; E Sepp; K Julge; T Voor; M Mikelsaar
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

6.  Regulation of the lic operon of Bacillus subtilis and characterization of potential phosphorylation sites of the LicR regulator protein by site-directed mutagenesis.

Authors:  S Tobisch; J Stülke; M Hecker
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

7.  Regulation of the glv operon in Bacillus subtilis: YfiA (GlvR) is a positive regulator of the operon that is repressed through CcpA and cre.

Authors:  H Yamamoto; M Serizawa; J Thompson; J Sekiguchi
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

8.  Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325.

Authors:  John J Iandolo; Veronica Worrell; Kajetan H Groicher; Yudong Qian; Runying Tian; Steve Kenton; Angela Dorman; Honggui Ji; Shaoping Lin; Phoebe Loh; Sulan Qi; Hua Zhu; B A Roe
Journal:  Gene       Date:  2002-05-01       Impact factor: 3.688

9.  Carbon catabolite repression in bacteria.

Authors:  J Stülke; W Hillen
Journal:  Curr Opin Microbiol       Date:  1999-04       Impact factor: 7.934

10.  A newborn mouse model for the study of intestinal pathogenesis of shigellosis.

Authors:  M I Fernandez; A Thuizat; T Pedron; M Neutra; A Phalipon; P J Sansonetti
Journal:  Cell Microbiol       Date:  2003-07       Impact factor: 3.715

View more
  17 in total

1.  Iridium piano stool complexes with activity against S. aureus and MRSA: it is past time to truly think outside of the box.

Authors:  Christine M DuChane; George W Karpin; Marion Ehrich; Joseph O Falkinham; Joseph S Merola
Journal:  Medchemcomm       Date:  2019-05-14       Impact factor: 3.597

2.  Altered Immunity of Laboratory Mice in the Natural Environment Is Associated with Fungal Colonization.

Authors:  Frank Yeung; Ying-Han Chen; Jian-Da Lin; Jacqueline M Leung; Caroline McCauley; Joseph C Devlin; Christina Hansen; Alex Cronkite; Zac Stephens; Charlotte Drake-Dunn; Yi Fulmer; Bo Shopsin; Kelly V Ruggles; June L Round; P'ng Loke; Andrea L Graham; Ken Cadwell
Journal:  Cell Host Microbe       Date:  2020-03-24       Impact factor: 21.023

Review 3.  Cetylpyridinium Chloride: Mechanism of Action, Antimicrobial Efficacy in Biofilms, and Potential Risks of Resistance.

Authors:  Xiaojun Mao; David L Auer; Wolfgang Buchalla; Karl-Anton Hiller; Tim Maisch; Elmar Hellwig; Ali Al-Ahmad; Fabian Cieplik
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

4.  Retapamulin Activity Against Pediatric Strains of Mupirocin-resistant Methicillin-resistant Staphylococcus aureus.

Authors:  Ami B Patel; Jennifer Lighter; Yi Fulmer; Richard Copin; Adam J Ratner; Bo Shopsin
Journal:  Pediatr Infect Dis J       Date:  2021-07-01       Impact factor: 3.806

5.  Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses.

Authors:  Kevin T Kavanagh
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-19       Impact factor: 4.887

6.  Comparison of Methicillin-Resistant Staphylococcus aureus Isolates from Cellulitis and from Osteomyelitis in a Taiwan Hospital, 2016-2018.

Authors:  Kuo-Ti Peng; Tsung-Yu Huang; Yao-Chang Chiang; Yu-Yi Hsu; Fang-Yi Chuang; Chiang-Wen Lee; Pey-Jium Chang
Journal:  J Clin Med       Date:  2019-06-07       Impact factor: 4.241

7.  Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  Y López; M Tato; D Gargallo-Viola; R Cantón; J Vila; I Zsolt
Journal:  PLoS One       Date:  2019-10-09       Impact factor: 3.240

8.  Genetic Diversity of Composite Enterotoxigenic Staphylococcus epidermidis Pathogenicity Islands.

Authors:  Sylwia Banaszkiewicz; Jessica K Calland; Evangelos Mourkas; Samuel K Sheppard; Ben Pascoe; Jacek Bania
Journal:  Genome Biol Evol       Date:  2019-12-01       Impact factor: 3.416

Review 9.  Physics Comes to the Aid of Medicine-Clinically-Relevant Microorganisms through the Eyes of Atomic Force Microscope.

Authors:  Mateusz Cieśluk; Piotr Deptuła; Ewelina Piktel; Krzysztof Fiedoruk; Łukasz Suprewicz; Paulina Paprocka; Patrycja Kot; Katarzyna Pogoda; Robert Bucki
Journal:  Pathogens       Date:  2020-11-20

10.  Genomic epidemiology of methicillin-resistant and -susceptible Staphylococcus aureus from bloodstream infections.

Authors:  Joshua T Smith; Elissa M Eckhardt; Nicole B Hansel; Tahmineh Rahmani Eliato; Isabella W Martin; Cheryl P Andam
Journal:  BMC Infect Dis       Date:  2021-06-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.